摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methylhexansaeurechlorid | 50599-73-0

中文名称
——
中文别名
——
英文名称
4-Methylhexansaeurechlorid
英文别名
4-methyl-hexanoyl chloride;4-methylhexanoyl chloride
4-Methylhexansaeurechlorid化学式
CAS
50599-73-0
化学式
C7H13ClO
mdl
——
分子量
148.633
InChiKey
SIZLIQXWCKQORP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    203.58°C (rough estimate)
  • 密度:
    0.9677

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    4-Methylhexansaeurechlorid盐酸羟胺potassium carbonate 作用下, 以 乙酸乙酯 为溶剂, 反应 12.0h, 生成 N-hydroxy-4-methylhexanamide
    参考文献:
    名称:
    1,4,2-二恶唑-5-酮分子内C-H酰胺化钌(II)-催化对映选择性γ-内酰胺形成
    摘要:
    我们报告了 Ru 催化的 1,4,2-二恶唑-5-酮的对映选择性环化,通过分子内羰基硝基 CH 插入以高达 97% 的产率和 98% 的 ee 提供 γ-内酰胺。通过使用手性二苯基乙二胺 (dpen) 作为带有吸电子芳基磺酰基取代基的配体,反应发生时具有显着的化学和对映选择性;竞争性的 Curtius 型重排在很大程度上被抑制了。对映选择性氮烯插入烯丙基/炔丙基 CH 键也实现了对 C=C 和 C≡C 键的显着耐受性。
    DOI:
    10.1021/jacs.9b00535
  • 作为产物:
    描述:
    alkaline earth salt of/the/ methylsulfuric acid 在 三氯化磷 作用下, 生成 4-Methylhexansaeurechlorid
    参考文献:
    名称:
    Dewael; Weckering, Bulletin des Societes Chimiques Belges, 1924, vol. 33, p. 503
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Studies on hypolipidemic agents. II Synthesis of 1-arenesulfonyloxy-2-alkanone derivatives as potent esterase inhibitors and hypolipidemic agents.
    作者:KAZUO OGAWA、TADAFUMI TERADA、YOSHIYUKI MURANAKA、TOSHIHIRO HAMAKAWA、SADAO HASHIMOTO、SETSURO FUJII
    DOI:10.1248/cpb.34.3252
    日期:——
    Many 2-oxoalkyl arenesulfonate derivatives having straight or branched alkyl chains of different lengths, 2-oxoalkyl bis-arenesulfonate derivatives, and alkyl arenesulfonate derivatives having a ketal moiety at the 2-position on the alkyl chain were synthesized, and their esterase-inhibitory activities, as well as hypolipidemic activities, were evaluated.Among these compounds, 1-(2, 4, 6-trimethylbenzenesulfonyloxy)-2-dodecanone (III-1u), and 1-(2, 3, 4, 6-tetramethylbenzenesulfonyloxy)-2-hexanone (III-1w), -2-octanone (III-1x) and -2-decanone (III-1y) exhibited potent esterase-inhibitory activities (IC50=3×10-10, 2×10-10, 2×10<-10> and 3×<-11>M, respectively). However, the sulfonate (XV) having a ketal moiety on the alkyl chain and the bis-sulfonate (XVI) exhibited low inhibitory activities toward esterase in comparison with III and XII. Most of the compounds III and some of the compounds XII exhibited potent hypolipidemic activities corresponding to more than 50% lipid-lowering effect (plasma triglyceride and cholesterol ester) in vivo. The structure-activity relatioinships of these compounds are discussed.
    合成了许多具有直链或支链不同长度烷基链的2-氧代烷基芳磺酸盐衍生物、2-氧代烷基双芳磺酸盐衍生物以及在烷基链的2-位具有缩酮部分的烷基芳磺酸盐衍生物,并评估了它们的酯酶抑制活性及降血脂活性。在这些化合物中,1-(2,4,6-三甲基苯磺酰氧基)-2-十二烷酮(III-1u)、1-(2,3,4,6-四甲基苯磺酰氧基)-2-己烷酮(III-1w)、-2-辛烷酮(III-1x)和-2-癸烷酮(III-1y)表现出强效的酯酶抑制活性(IC50分别为3×10-10、2×10-10、2×10-10和3×10-11M)。然而,相对于III和XII,具有烷基链上缩酮部分的磺酸盐(XV)和双磺酸盐(XVI)对酯酶的抑制活性较低。大多数化合物III和部分化合物XII表现出强效的降血脂活性,对应于体内超过50%的脂质降低效果(血浆甘油三酯和胆固醇酯)。讨论了这些化合物的构效关系。
  • γ,δ,ε-C(sp<sup>3</sup>)–H Functionalization through Directed Radical H-Abstraction
    作者:Tao Liu、Tian-Sheng Mei、Jin-Quan Yu
    DOI:10.1021/jacs.5b02065
    日期:2015.5.13
    Aliphatic amides are selectively functionalized at the γ- and δ-positions through directed radical 1,5 and 1,6 H-abstractions, respectively. The initially formed γ- or δ-lactams are intercepted by N-iodosuccinimide and trimethylsilyl azide, leading to double and triple C-H functionalizations at the γ-, δ-, and ε-positions. This new reactivity is exploited to convert alkyls into amino alcohols and allylic
    脂肪族酰胺分别通过定向自由基 1,5 和 1,6 H-抽象在 γ- 和 δ- 位选择性地官能化。最初形成的γ-或δ-内酰胺被N-碘代琥珀酰亚胺和三甲基甲硅烷基叠氮化物拦截,导致γ-、δ-和ε-位的双和三CH官能化。这种新的反应性被用来将烷基转化为氨基醇和烯丙胺。
  • Cannabinoid receptor ligands and uses thereof
    申请人:Pfizer Inc.
    公开号:US20040077650A1
    公开(公告)日:2004-04-22
    Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the modulation of the cannabinoid receptors in animals are described herein. 1
    本文描述了作为大麻素受体配体的化合物(I)及其在治疗与动物体内大麻素受体调节相关疾病中的用途。
  • Optically active cyano-biphenyl compounds and liquid crystal materials
    申请人:The Secretary of State for Defence in Her Britannic Majesty's Government
    公开号:US04077260A1
    公开(公告)日:1978-03-07
    Liquid crystal compounds are disclosed having the formula ##STR1## where p is an integer having a value from 0 to 5 inclusive. These materials are optically active and cholesterogenic and may be used in an electro-optical display device either on their own or in admixture with nematogenic materials having a formula ##STR2## where i has a value from 0 to 5 inclusive and j is 0 or 1. These last mentioned mixtures may be thermochromic and employed in a temperature sensing device.
    本发明公开了具有以下式子的液晶化合物:##STR1## 其中p是一个整数,其值从0到5(含)不等。这些材料具有光学活性和螺旋体生成性,可以单独使用或与具有以下式子的向列相材料混合在一起用于电光显示器件:##STR2## 其中i的值从0到5(含)不等,j为0或1。这些最后提到的混合物可以是热致变色的,并用于温度传感器件。
  • PHENOL ESTER AS PERFUMING INGREDIENT
    申请人:Chapuis Christian
    公开号:US20120045408A1
    公开(公告)日:2012-02-23
    The present invention relates to the field of perfumery. More particularly, it concerns the use as perfuming ingredients of certain phenol esters of formula wherein R represents a C 2-6 branched alkyl group or a C 2-6 linear or branched alkenyl group or cyclopropyl containing hydrocarbon group. The present invention concerns also the compositions or articles containing such compounds.
    本发明涉及香料领域。更具体地,它涉及使用某些公式为R表示C2-6支链烷基或C2-6线性或支链烯基或含环丙基的碳氢基团的酚酸酯作为香料成分。本发明还涉及含有这些化合物的组合物或物品。
查看更多